Scandinavian Biopharma extends its agreement with USAMMDA and obtains additional financial support
In 2020, Scandinavian Biopharma entered into an agreement with the United States Army Medical Materiel Development Activity (USAMMDA) to fund manufacturing and development activities for its ETEC diarrhoea vaccine, ETVAX®. The agreement has now been extended, providing additional financial support. The objective of USAMMDA’s financial support is to accelerate the development and approval of the […]